Showing results (1341-1350 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|March 10, 2006
Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapyHitendra Patel, Ronald Stoller, Miklos Auber, et al.
Investigational New Drugs|May 13, 2008
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principlesSharon L Sanborn, Matthew M Cooney, Afshin Dowlati, et al.
Investigational New Drugs|May 14, 2008
Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-dionesS Chandrappa, S B Benaka Prasad, K Vinaya, et al.
Investigational New Drugs|November 1, 1991
Terephthalamidine: past and futureJ S Fisherman, E M Cline, J Plowman, et al.
Investigational New Drugs|November 1, 1991
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin. A Southwest Oncology Group studyR P Whitehead, T R Fleming, J S Macdonald, et al.
Investigational New Drugs|November 1, 1991
Phase II evaluation of amonafide in renal cell carcinoma. A Southwest Oncology Group studyC S Higano, P Goodman, J B Craig, et al.
Investigational New Drugs|November 1, 1991
Phase I trial of FK973: description of a delayed vascular leak syndromeR Pazdur, D H Ho, K Daugherty, et al.
Investigational New Drugs|May 2, 2008
Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignanciesPriscila H Goncalves, Francine High, Paul Juniewicz, et al.
Investigational New Drugs|December 16, 1998
Phase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemiaS A Johnson, D Catovsky, J A Child, et al.
Investigational New Drugs|December 16, 1998
A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neckJ J Beitler, R V Smith, H Haynes, et al.
Pageof 372